Dr. Giordano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1414 S Orange Ave
Orlando, FL 32806Phone+1 407-841-5111Fax+1 904-346-0113
Education & Training
- Orlando HealthResidency, Emergency Medicine, 1993 - 1996
- University of Virginia School of MedicineClass of 1993
Certifications & Licensure
- FL State Medical License 1995 - 2025
- American Board of Emergency Medicine Emergency Medicine
Awards, Honors, & Recognition
- Fellow (FACEP) American College of Emergency Physicians
Publications & Presentations
PubMed
- 157 citationsA Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure InfectionMichael W. Dunne, Sailaja Puttagunta, Philip Giordano, Dainis Krievins, Michael Zelasky
Clinical Infectious Diseases. 2016-03-01 - 52 citationsSequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and ...Philip Giordano, James Song, Peter Pertel, Janet Herrington, Steven F Kowalsky
International Journal of Antimicrobial Agents. 2005-11-01 - 58 citationsTreating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanateBenjamin A. Lipsky, Philip Giordano, Shurjeel Choudhri, James Song
The Journal of Antimicrobial Chemotherapy. 2007-08-01
Press Mentions
- FDA Approves XenletaAugust 21st, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: